SavedAdd your journal

Journals / Türkderm Türk deri hastalıkları ve frengi arşivi / 2021 / Cilt: 55 - Sayı: 4

Arbor cutis resulting from using topical imiquimod for treating actinic keratosis and squamous cell carcinoma in situ

Aktinik keratoz ve skuamöz hücreli karsinoma in situ tedavisinde topikal imikimod kullanımına sekonder hiperkeratoz

Neslihan Akdoğan
Gonca Elçin
Gülsün Hazan Tabak
Pages
206–207
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

Akdoğan, N., Elçin, G., Tabak, G. H. (2022). Arbor cutis resulting from using topical imiquimod for treating actinic keratosis and squamous cell carcinoma in situ. Türkderm Türk deri hastalıkları ve frengi arşivi, Cilt: 55 - Sayı: 4, 206–207. https://ajindex.com/articles/622455

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Urosevic M, Dummer R: Role of imiquimod in skin cancer treatment. Am J Clin Dermatol 2004;5:453-8
  2. Knabel P, Cleaver L: Arbor cutis: Hyperkeratotic plaque secondary to the use of imiquimod for the treatment of squamous cell carcinoma in situ. Dermatol Surg 2013;39:655-7
  3. Desai T, Chen CL, Desai A, Kirby W: Basic pharmacology of topical imiquimod, 5-fluorouracil and diclofenac for the dermatologic surgeon. Dermatol Surg 2012;38:97-103
  4. Shimizu I, Cruz A, Chang KH, Dufresne RG: Treatment of squamous cell carcinoma in situ: A review. Dermatol Surg 2011;37:1394-411
  5. Patel GK, Goodwin R, Chawla M, et al.: Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen’s disease): A randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2006;54:1025-32
  6. Mosher JS, Lio P: Cytokine dermatitis and febrile seizure from imiquimod. Pediatrics 2012;129:e519-22.